SPARNEFRI

Serial Number 90072534
606

Registration Progress

Application Filed
Jul 24, 2020
Under Examination
Mar 16, 2021
Approved for Publication
Jan 19, 2021
Published for Opposition
Jan 19, 2021
Registered

Trademark Image

SPARNEFRI

Basic Information

Serial Number
90072534
Filing Date
July 24, 2020
Published for Opposition
January 19, 2021
Abandonment Date
October 18, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 18, 2021
Classes
005

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner Before Publication #1
03
SAN DIEGO, CA

TRAVERE THERAPEUTICS, INC.

Owner at Publication
03
SAN DIEGO, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Oct 18, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 18, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 16, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 19, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 19, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 30, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 14, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 11, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 11, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 16, 2020 CPRA R PRIORITY ACTION WRITTEN Loading...
Nov 16, 2020 GPRA F PRIORITY ACTION E-MAILED Loading...
Nov 16, 2020 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Nov 10, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 24, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005